These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9856776
21. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations. Brindley N, Matin A, Khan NA. Exp Parasitol; 2009 Mar; 121(3):254-6. PubMed ID: 19071116 [Abstract] [Full Text] [Related]
22. Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Turner ML, Cockerell EJ, Brereton HM, Badenoch PR, Tea M, Coster DJ, Williams KA. Int J Parasitol; 2005 Aug; 35(9):981-90. PubMed ID: 15964573 [Abstract] [Full Text] [Related]
24. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii]. Yin GR, Meng XL, Ma GY, Ma XM. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798 [Abstract] [Full Text] [Related]
25. Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Sharma S, Athmanathan S, Ata-Ur-Rasheed M, Garg P, Rao GN. Indian J Ophthalmol; 2001 Sep; 49(3):181-6. PubMed ID: 15887727 [Abstract] [Full Text] [Related]
26. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells. Saitoh-Inagawa W, Hiroi T, Yanagita M, Iijima H, Uchio E, Ohno S, Aoki K, Kiyono H. Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613 [Abstract] [Full Text] [Related]
28. Failure of Acanthamoeba castellanii to produce intraocular infections. Clarke DW, Alizadeh H, Niederkorn JY. Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2472-8. PubMed ID: 15980238 [Abstract] [Full Text] [Related]
29. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Masinick SA, Montgomery CP, Montgomery PC, Hazlett LD. Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987 [Abstract] [Full Text] [Related]
30. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Garate M, Marchant J, Cubillos I, Cao Z, Khan NA, Panjwani N. Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1056-62. PubMed ID: 16505041 [Abstract] [Full Text] [Related]
31. Recent advances in the treatment of Acanthamoeba keratitis. Kumar R, Lloyd D. Clin Infect Dis; 2002 Aug 15; 35(4):434-41. PubMed ID: 12145728 [Abstract] [Full Text] [Related]
35. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL. Parasite Immunol; 2005 May 15; 27(1-2):29-35. PubMed ID: 15813720 [Abstract] [Full Text] [Related]
36. Role of mucosal secretory immunity in the development of an amebiasis vaccine. Ravdin JI, Kelsall BL. Am J Trop Med Hyg; 1994 May 15; 50(5 Suppl):36-41. PubMed ID: 8203722 [Abstract] [Full Text] [Related]
38. Acanthamoebae bind to rabbit corneal epithelium in vitro. Panjwani N, Zhao Z, Baum J, Hazlett LD, Yang Z. Invest Ophthalmol Vis Sci; 1997 Aug 15; 38(9):1858-64. PubMed ID: 9286276 [Abstract] [Full Text] [Related]
40. Impaired innate immunity of ocular surface is the key bridge between extended contact lens wearing and occurrence of Acanthamoeba keratitis. Li L, Sun X. Med Hypotheses; 2008 Aug 15; 70(2):260-4. PubMed ID: 17689022 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]